Serum amyloid A protein has been undervalued as a biomarker of COVID‐19

This publication has 13 references indexed in Scilit:

• On the Alert for Cytokine Storm: Immunopathology in COVID‐19
  Arthritis & Rheumatology, 2020
• Cytokine release syndrome in severe COVID-19
  Science, 2020
• Neutrophil‐to‐lymphocyte ratio and lymphocyte‐to‐C‐reactive protein ratio in patients with severe coronavirus disease 2019 (COVID‐19): A meta‐analysis
  Journal of Medical Virology, 2020
• COVID-19 and diabetes: Knowledge in progress
  Diabetes Research and Clinical Practice, 2020
• Diabetes is a risk factor for the progression and prognosis of COVID‐19
  Diabetes/Metabolism Research and Reviews, 2020
• Serum amyloid A binds to fibrin(ogen), promoting fibrin amyloid formation
  Scientific Reports, 2019
• IL-1β/IL-6/CRP and IL-18/ferritin: Distinct Inflammatory Programs in Infections
  PLOS Pathogens, 2016
• C-reactive protein concentrations across the mood spectrum in bipolar disorder: a systematic review and meta-analysis
  The Lancet Psychiatry, 2016
• Serum amyloid A impairs the antiinflammatory properties of HDL
  Journal of Clinical Investigation, 2015
• Association between serum amyloid A and obesity: a meta-analysis and systematic review
  Inflammation Research, 2010